Juxtapid and Benicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Juxtapid (lomitapide mesylate) and Benicar (olmesartan medoxomil). Common drug interactions include diarrhoea among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Juxtapid and Benicar. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Juxtapid?

Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.



On Jul, 12, 2026

22 people who take Juxtapid and Benicar together, and have interactions are studied.

Juxtapid and Benicar drug interactions.

What are the common drug interactions of Juxtapid and Benicar, by gender? *:

female:

  1. Diarrhoea
  2. Hepatic enzyme increased
  3. Abdominal discomfort
  4. Influenza like illness
  5. Muscle spasms (muscle contraction)
  6. Nausea (feeling of having an urge to vomit)
  7. Red blood cell count decreased
  8. Weight decreased
  9. White blood cell count decreased
  10. Abdominal distension

male:

  1. Weight decreased
  2. Hunger
  3. Hypovolaemia (a decreased volume of circulating blood in the body)
  4. Loss of consciousness
  5. Myalgia (muscle pain)
  6. Myositis (inflammation of the muscles)
  7. Nausea (feeling of having an urge to vomit)
  8. Nerve compression
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Vomiting

What are the common drug interactions of Juxtapid and Benicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Hepatic enzyme increased
  6. Hypotension (abnormally low blood pressure)
  7. Hypovolaemia (a decreased volume of circulating blood in the body)
  8. Loss of consciousness
  9. Nausea (feeling of having an urge to vomit)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

60+:

  1. Muscle spasms (muscle contraction)
  2. Weight decreased
  3. Red blood cell count decreased
  4. White blood cell count decreased
  5. Abdominal pain upper
  6. Apathy
  7. Arthropathy
  8. Asthenia (weakness)
  9. Chills (felling of cold)
  10. Decreased appetite

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 3 people, 13.64%
  2. Inclusion Body Myositis (inflammatory muscle disease, slowly progressive weakness and wasting): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Juxtapid and Benicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Juxtapid and Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Juxtapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lomitapide mesylate and olmesartan medoxomil (the active ingredients of Juxtapid and Benicar, respectively), and Juxtapid and Benicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: